The tissue-engineered vascular graft - Past, present, and future

Tissue Engineering - Part B: Reviews

Volumn 22, Issue 1, 2016, Pages 68-100

  Pashneh Tala, Samand ^a   MacNeil, Sheila ^a   Claeyssens, Frederik ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; GRAFTS; NATURAL POLYMERS; SCAFFOLDS (BIOLOGY); SELF ASSEMBLY; TISSUE;

BYPASS GRAFTING; CARDIO-VASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFTING; PERIPHERAL ARTERIES; REVASCULARIZATION; SELF ASSEMBLY PROCESS; STATE OF THE ART; TISSUE ENGINEERED VASCULAR GRAFTS;

BLOOD VESSELS;

HYBRID POLYMER; NATURAL POLYMER; POLYMER; SYNTHETIC POLYMER; UNCLASSIFIED DRUG;

BLOOD VESSEL GRAFT; BLOOD VESSEL SHUNT; CARDIOVASCULAR DISEASE; DECELLULARIZED NATURAL MATRIX; FUTUROLOGY; HUMAN; IN VIVO STUDY; MEMBRANE; PRIORITY JOURNAL; PROCEDURES; REVIEW; TISSUE ENGINEERING; TISSUE SCAFFOLD;

EID: 84994509012     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2015.0100     Document Type: Review

References (280)

1. Zoghbi, W.A., Duncan, T., Antman, E., Barbosa, M., Champagne, B., Chen, D., Gamra, H., Harold, J.G., Josephson, S., Komajda, M., Logstrup, S., Mayosi, B.M., Mwangi, J., Ralston, J., Sacco, R.L., Sim, K.H., Smith, S.C., Jr, Vardas, P.E., and Wood, D.A. Sustainable development goals and the future of cardiovascular health: a statement from the global cardiovascular disease task-force. J Am Coll Cardiol 64, 1385, 2014.
2. Mathers, C.D., and Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3, e442, 2006.
3. Abdulhannan, P., Russell, D.A., and Homer-Vanniasinkam, S. Peripheral arterial disease: a literature review. Br Med Bull 104, 21, 2012.
4. Antoniou, G.A., Chalmers, N., Georgiadis, G.S., Lazarides, M.K., Antoniou, S.A., Serracino-Inglott, F., Smyth, J.V., and Murray, D. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 57, 242, 2013.
5. Conte, M.S. Critical appraisal of surgical revascularization for critical limb ischemia. J Vasc Surg 57, 8S, 2013.
6. Mohr, F.W., Morice, M.-C., Kappetein, A.P., Feldman, T.E., Ståhle, E., Colombo, A., Mack, M.J., Holmes, D.R., Jr, Morel, M., Van Dyck, N., Houle, V.M., Dawkins, K.D., and Serruys, P.W. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381, 629, 2013.
7. Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G., Mack, M., Yang, M., Cohen, D.J., Rosenberg, Y., Solomon, S.D., Desai, A.S., Gersh, B.J., Magnuson, E.A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J.E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C.R., Muratov, V., Bansilal, S., King, S., Bertrand, M., and Fuster, V. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367, 2375, 2012.
8. Weintraub, W.S., Grau-Sepulveda, M.V., Weiss, J.M., O'Brien, S.M., Peterson, E.D., Kolm, P., Zhang, Z., Klein, L.W., Shaw, R.E., McKay, C., Ritzenthaler, L.L., Popma, J.J., Messenger, J.C., Shahian, D.M., Grover, F.L., Mayer, J.E., Shewan, C.M., Garratt, K.N., Moussa, I.D., Dangas, G.D., and Edwards, F.H. Comparative effectiveness of revascularization strategies. N Engl J Med 366, 1467, 2012.
9. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., and Turner, M.B. Heart disease and stroke statistics - 2013 update a report from the american heart association. Circulation 127, e6, 2013.
10. Masden, D.L., Seruya, M., and Higgins, J.P. A systematic review of the outcomes of distal upper extremity bypass surgery with arterial and venous conduits. J Hand Surg 37, 2362, 2012.
11. Athanasiou, T., Saso, S., Rao, C., Vecht, J., Grapsa, J., Dunning, J., Lemma, M., and Casula, R. Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition - which conduit offers better patency? A systematic review and meta-analysis. Eur J Cardiothorac Surg 40, 208, 2011.
12. Cho, K.R., Kim, J.-S., Jae-Sung, C., and Kim, K.-B. Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg 29, 511, 2006.
13. Goldman, S., Zadina, K., Moritz, T., Ovitt, T., Sethi, G., Copeland, J.G., Thottapurathu, L., Krasnicka, B., Ellis, N., Anderson, R.J., and Henderson, W. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 44, 2149, 2004.
14. Harskamp, R.E., Lopes, R.D., Baisden, C.E., de Winter, R.J., and Alexander, J.H. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg 257, 824, 2013.
15. Klinkert, P., Post, P.N., Breslau, P.J., and van Bockel, J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A Review of the literature. Eur J Vasc Endovasc Surg 27, 357, 2004.
16. Chew, D.K.W., Owens, C.D., Belkin, M., Donaldson, M.C., Whittemore, A.D., Mannick, J.A., and Conte, M.S. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein. J Vasc Surg 35, 1085, 2002.
17. Taylor, L.M., Jr, Edwards, J.M., Brant, B., Phinney, E.S., and Porter, J.M. Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein. Am J Surg 153, 505, 1987.
18. Brewster, D.C. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg 25, 365, 1997.
19. Chlupác, J., Filova, E., and Bacáková, L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res 58, S119, 2009.
20. Hadinata, I.E., Hayward, P.A.R., Hare, D.L., Matalanis, G.S., Seevanayagam, S., Rosalion, A., and Buxton, B.F. Choice of conduit for the right coronary system: 8-year analysis of radial artery patency and clinical outcomes trial. Ann Thorac Surg 88, 1404, 2009.
21. Shah, P.J., Bui, K., Blackmore, S., Gordon, I., Hare, D.L., Fuller, J., Seevanayagam, S., and Buxton, B.F. Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients. Eur J Cardiothorac Surg 27, 870, 2005.
22. Chard, R.B., Johnson, D.C., Nunn, G.R., and Cartmill, T.B. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. J Thorac Cardiovasc Surg 94, 132, 1987.
23. Hehrlein, F.W., Schlepper, M., Loskot, F., Scheld, H.H., Walter, P., and Mulch, J. The use of expanded polytetra-fluoroethylene (PTFE) grafts for myocardial revascularization. J Cardiovasc Surg (Torino) 25, 549, 1984.
24. Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G.R.; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45, S5, 2007.
25. Ballotta, E., Renon, L., Toffano, M., and Da Giau, G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg 38, 1051, 2003.
26. Green, R.M., Abbott, W.M., Matsumoto, T., Wheeler, J.R., Miller, N., Veith, F.J., Money, S., and Garrett, H.E. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31, 417, 2000.
27. Johnson, W.C., and Lee, K.K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32, 268, 2000.
28. AbuRahma, A.F., Robinson, P.A., and Holt, S.M. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 126, 594, 1999.
29. Deutsch, M., Meinhart, J., Zilla, P., Howanietz, N., Gorlitzer, M., Froeschl, A., Stuempflen, A., Bezuidenhout, D., and Grabenwoeger, M. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J Vasc Surg 49, 352, 2009.
30. Eslami, M.H., Gangadharan, S.P., Belkin, M., Donaldson, M.C., Whittemore, A.D., and Conte, M.S. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury? J Vasc Surg 34, 923, 2001.
31. Burkel, W.E., Vinter, D.W., Ford, J.W., Kahn, R.H., Graham, L.M., and Stanley, J.C. Sequential studies of healing in endothelial seeded vascular prostheses: histologic and ultrastructure characteristics of graft incorporation. J Surg Res 30, 305, 1981.
32. Sarkar, S., Salacinski, H.J., Hamilton, G., and Seifalian, A.M. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur J Vasc Endovasc Surg 31, 627, 2006.
33. Haruguchi, H., and Teraoka, S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs 6, 227, 2003.
34. Tiwari, A., Cheng, K.-S., Salacinski, H., Hamilton, G., and Seifalian, A.M. Improving the patency of vascular bypass grafts: the role of suture materials and surgical techniques on reducing anastomotic compliance mismatch. Eur J Vasc Endovasc Surg 25, 287, 2003.
35. Greenwald, S.E., and Berry, C.L. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol 190, 292, 2000.
36. Lemson, M.S., Tordoir, J.H.M., Daemen, M.J.A.P, and Kitslaar, P.J.E.H.M. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 19, 336, 2000.
37. Ballyk, P.D., Walsh, C., Butany, J., and Ojha, M. Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech 31, 229, 1997.
38. Davies, M.G., and Hagen, P.-O. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 9, 7, 1995.
39. FitzGibbon, G.M., Leach, A.J., Kafka, H.P., and Keon, W.J. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 17, 1075, 1991.
40. Van der Wal, A.C., Becker, A.E., Elbers, J.R., and Das, P.K. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothorac Surg 6, 469, 1992.
41. Cox, J.L., Chiasson, D.A., and Gotlieb, A.I. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 34, 45, 1991.
42. Padberg, F.T., Jr, Calligaro, K.D., and Sidawy, A.N. Complications of arteriovenous hemodialysis access: recognition and management. J Vasc Surg 48, S55, 2008.
43. Zetrenne, E., McIntosh, B.C., McRae, M.H., Gusberg, R., Evans, G.R.D., and Narayan, D. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 80, 113, 2007.
44. Chiesa, R., Astore, D., Frigerio, S., Garriboli, L., Piccolo, G., Castellano, R., Scalamogna, M., Odero, A., Pirrelli, S., and Biasi, G. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 102, 238, 2002.
45. Bunt, T.J. Vascular graft infections: an update. Cardiovasc Surg 9, 225, 2001.
46. Mertens, R.A., O'Hara, P.J., Hertzer, N.R., Krajewski, L.P., and Beven, E.G. Surgical management of infrainguinal arterial prosthetic graft infections: review of a thirty-five-year experience. J Vasc Surg 21, 782, 1995.
47. Ballotta, E., Renon, L., De Rossi, A., Barbon, B., Terranova, O., and Da Giau, G. Prospective randomized study on reversed saphenous vein infrapopliteal bypass to treat limb-threatening ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow. J Vasc Surg 40, 732, 2004.
48. Baguneid, M.S., Seifalian, A.M., Salacinski, H.J., Murray, D., Hamilton, G., and Walker, M.G. Tissue engineering of blood vessels. Br J Surg 93, 282, 2006.
49. Owida, A.A., Do, H., and Morsi, Y.S. Numerical analysis of coronary artery bypass grafts: an over view. Comput Methods Programs Biomed 108, 689, 2012.
50. Scharn, D.M., Daamen, W.F., van Kuppevelt, T.H., and van der Vliet, J.A. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design. Eur J Vasc Endovasc Surg 43, 66, 2012.
51. John, L.C.H. Biomechanics of coronary artery and bypass graft disease: potential new approaches. Ann Thorac Surg 87, 331, 2009.
52. Weinberg, C.B., and Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397, 1986.
53. Shinoka, T., Shum-Tim, D., Ma, P.X., Tanel, R.E., Isogai, N., Langer, R., Vacanti, J.P., and Mayer, J.E., Jr. Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering. J Thorac Cardiovasc Surg 115, 536, 1998.
54. Hibino, N., McGillicuddy, E., Matsumura, G., Ichihara, Y., Naito, Y., Breuer, C., and Shinoka, T. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 139, 431, 2010.
55. Shin'oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., Sakamoto, T., Nagatsu, M., and Kurosawa, H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129, 1330, 2005.
56. Kim, S.-J., Kim, W.-H., Lim, H.-G., and Lee, J.-Y. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 136, 108, 2008.
57. Giannico, S., Hammad, F., Amodeo, A., Michielon, G., Drago, F., Turchetta, A., Di Donato, R., and Sanders, S.P. Clinical outcome of 193 extracardiac Fontan patients the first 15 years. J Am Coll Cardiol 47, 2065, 2006.
58. Mirensky, T.L., Nelson, G.N., Brennan, M.P., Roh, J.D., Hibino, N., Yi, T., Shinoka, T., and Breuer, C.K. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg 44, 1127, 2009.
59. Niklason, L.E., and Langer, R. Advances in tissue engineering of blood vessels and other tissues. Transpl Immunol 5, 303, 1997.
60. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. Functional arteries grown in vitro. Science 284, 489, 1999.
61. Wise, S.G., Byrom, M.J., Waterhouse, A., Bannon, P.G., Ng, M.K.C., and Weiss, A.S. A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties. Acta Biomater 7, 295, 2011.
62. Konig, G., McAllister, T.N., Dusserre, N., Garrido, S.A., Iyican, C., Marini, A., Fiorillo, A., Avila, H., Wystrychowski, W., Zagalski, K., Maruszewski, M., Jones, A.L., Cierpka, L., de la Fuente, L.M., and L'Heureux, N. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30, 1542, 2009.
63. L'Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., Chronos, N.A.F., Kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., and McAllister, T.N. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12, 361, 2006.
64. Lamm, P., Juchem, G., Milz, S., Schuffenhauer, M., and Reichart, B. Autologous endothelialized vein allograft a solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation 104, I108, 2001.
65. L'Heureux, N., Pâquet, S., Labbé, R., Germain, L., and Auger, F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12, 47, 1998.
66. Niklason, L.E., Abbott, W., Gao, J., Klagges, B., Hirschi, K.K., Ulubayram, K., Conroy, N., Jones, R., Vasanawala, A., Sanzgiri, S., and Langer, R. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 33, 628, 2001.
67. Quint, C., Arief, M., Muto, A., Dardik, A., and Niklason, L.E. Allogeneic human tissue-engineered blood vessel. J Vasc Surg 55, 790, 2012.
68. Quint, C., Kondo, Y., Manson, R.J., Lawson, J.H., Dardik, A., and Niklason, L.E. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci 108, 9214, 2011.
69. Dahl, S.L.M., Kypson, A.P., Lawson, J.H., Blum, J.L., Strader, J.T., Li, Y., Manson, R.J., Tente, W.E., DiBernardo, L., Hensley, M.T., Carter, R., Williams, T.P., Prichard, H.L., Dey, M.S., Begelman, K.G., and Niklason, L.E. Readily available tissue-engineered vascular grafts. Sci Transl Med 3, 68ra9, 2011.
70. Tsutsumi, H., Miyawaki, F., Arakawa, H., Tsuji, T., and Tanigawa, M. Experience of vein grafting in Göttingen minipigs. Exp Anim 50, 191, 2001.
71. Dahl, S., Lawson, J.H., Prichard, H.L., Manson, R.J., Tente, W.E., Kypson, A.P., Blum, J.L., and Niklason, L.E. Abstracts from the emerging science series. Circulation 127, 2071, 2013.
72. Cummings, I., George, S., Kelm, J., Schmidt, D., Emmert, M.Y., Weber, B., Zünd, G., and Hoerstrup, S.P. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. Eur J Cardiothorac Surg 41, 167, 2012.
73. Hoerstrup, S.P., Mrcs, I.C., Lachat, M., Schoen, F.J., Jenni, R., Leschka, S., Neuenschwander, S., Schmidt, D., Mol, A., Günter, C., Gössi, M., Genoni, M., and Zund, G. Functional growth in tissue-engineered living, vascular grafts follow-up at 100 weeks in a large animal model. Circulation 114, I159, 2006.
74. Nieponice, A., Soletti, L., Guan, J., Hong, Y., Gharaibeh, B., Maul, T.M., Huard, J., Wagner, W.R., and Vorp, D.A. In Vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A 16, 1215, 2010.
75. He, W., Nieponice, A., Soletti, L., Hong, Y., Gharaibeh, B., Crisan, M., Usas, A., Peault, B., Huard, J., Wagner, W.R., and Vorp, D.A. Pericyte-based human tissue engineered vascular grafts. Biomaterials 31, 8235, 2010.
76. Matsumura, G., Isayama, N., Matsuda, S., Taki, K., Sakamoto, Y., Ikada, Y., and Yamazaki, K. Long-term results of cell-free biodegradable scaffolds for in situ tissue engineering of pulmonary artery in a canine model. Biomaterials 34, 6422, 2013.
77. Lu, G., Cui, S., Geng, X., Ye, L., Chen, B., Feng, Z., Zhang, J., and Li, Z. Design and preparation of polyurethane-collagen/heparin-conjugated polycaprolactone double-layer bionic small-diameter vascular graft and its preliminary animal tests. Chin Med J (Engl) 126, 1310, 2013.
78. Yokota, T., Ichikawa, H., Matsumiya, G., Kuratani, T., Sakaguchi, T., Iwai, S., Shirakawa, Y., Torikai, K., Saito, A., Uchimura, E., Kawaguchi, N., Matsuura, N., and Sawa, Y. In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding. J Thorac Cardiovasc Surg 136, 900, 2008.
79. Wu, W., Allen, R.A., and Wang, Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med 18, 1148, 2012.
80. Kuwabara, F., Narita, Y., Yamawaki-Ogata, A., Satake, M., Kaneko, H., Oshima, H., Usui, A., and Ueda, Y. Longterm results of tissue-engineered small-caliber vascular grafts in a rat carotid arterial replacement model. J Artif Organs 15, 399, 2012.
81. Thomas, L.V., and Nair, P.D. The effect of pulsatile loading and scaffold structure for the generation of a medial equivalent tissue engineered vascular graft. Biores Open Access 2, 227, 2013.
82. De Valence, S., Tille, J.-C., Mugnai, D., Mrowczynski, W., Gurny, R., Möller, M., and Walpoth, B.H. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials 33, 38, 2012.
83. Lin, S., Sandig, M., and Mequanint, K. Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells. Tissue Eng Part A 17, 1561, 2011.
84. McMahon, R.E., Qu, X., Jimenez-Vergara, A.C., Bashur, C.A., Guelcher, S.A., Goldstein, A.S., and Hahn, M.S. Hydrogel-electrospun mesh composites for coronary artery bypass grafts. Tissue Eng Part C Methods 17, 451, 2011.
85. Crapo, P.M., and Wang, Y. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials 31, 1626, 2010.
86. Hu, J., Sun, X., Ma, H., Xie, C., Chen, Y.E., and Ma, P.X. Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials 31, 7971, 2010.
87. Ju, Y.M., Choi, J.S., Atala, A., Yoo, J.J., and Lee, S.J. Bilayered scaffold for engineering cellularized blood vessels. Biomaterials 31, 4313, 2010.
88. Soletti, L., Hong, Y., Guan, J., Stankus, J.J., El-Kurdi, M.S., Wagner, W.R., and Vorp, D.A. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 6, 110, 2010.
89. Lee, K.-W., Stolz, D.B., and Wang, Y. Substantial expression of mature elastin in arterial constructs. Proc Natl Acad Sci 108, 2705, 2011.
90. Sharifpoor, S., Simmons, C.A., Labow, R.S., and Paul Santerre, J. Functional characterization of human coronary artery smooth muscle cells under cyclic mechanical strain in a degradable polyurethane scaffold. Biomaterials 32, 4816, 2011.
91. Iwasaki, K., Kojima, K., Kodama, S., Paz, A.C., Chambers, M., Umezu, M., and Vacanti, C.A. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 118, S52, 2008.
92. Haisch, A., Loch, D.A., David, J., Pruß, A., Hansen, R., and Sittinger, M. Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med Biol Eng Comput 38, 686, 2000.
93. Huynh, T.N., and Tranquillo, R.T. Fusion of concentrically layered tubular tissue constructs increases burst strength. Ann Biomed Eng 38, 2226, 2010.
94. Syedain, Z.H., Meier, L.A., Bjork, J.W., Lee, A., and Tranquillo, R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 32, 714, 2011.
95. Syedain, Z.H., Meier, L.A., Lahti, M.T., Johnson, S.L., and Tranquillo, R.T. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng Part A 20, 1726, 2014.
96. Swartz, D.D., Russell, J.A., and Andreadis, S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 288, H1451, 2005.
97. Yao, L., Liu, J., and Andreadis, S.T. Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels. Pharm Res 25, 1212, 2008.
98. Liu, J.Y., Swartz, D.D., Peng, H.F., Gugino, S.F., Russell, J.A., and Andreadis, S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 75, 618, 2007.
99. Bjork, J.W., Meier, L.A., Johnson, S.L., Syedain, Z.H., and Tranquillo, R.T. Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue. Tissue Eng Part A 18, 785, 2012.
100. Lovett, M., Eng, G., Kluge, J., Cannizzaro, C., Vunjak-Novakovic, G., and Kaplan, D.L. Tubular silk scaffolds for small diameter vascular grafts. Organogenesis 6, 217, 2010.
101. Enomoto, S., Sumi, M., Kajimoto, K., Nakazawa, Y., Takahashi, R., Takabayashi, C., Asakura, T., and Sata, M. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. J Vasc Surg 51, 155, 2010.
102. Soffer, L., Wang, X., Zhang, X., Kluge, J., Dorfmann, L., Kaplan, D.L., and Leisk, G. Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed 19, 653, 2008.
103. Marelli, B., Achilli, M., Alessandrino, A., Freddi, G., Tanzi, M.C., Farè, S., and Mantovani, D. Collagen-reinforced electrospun silk fibroin tubular construct as small calibre vascular graft. Macromol Biosci 12, 1566, 2012.
104. Achilli, M., Lagueux, J., and Mantovani, D. On the effects of UV-C and pH on the mechanical behavior, molecular conformation and cell viability of collagen-based scaffold for vascular tissue engineering. Macromol Biosci 10, 307, 2010.
105. Liang, W.-H., Kienitz, B.L., Penick, K.J., Welter, J.F., Zawodzinski, T.A., and Baskaran, H. Concentrated collagen-chondroitin sulfate scaffolds for tissue engineering applications. J Biomed Mater Res A 94A, 1050, 2010.
106. Girton, T.S., Oegema, T.R., Grassl, E.D., Isenberg, B.C., and Tranquillo, R.T. Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. J Biomech Eng 122, 216, 2000.
107. Barocas, V.H., Girton, T.S., and Tranquillo, R.T. Engineered alignment in media equivalents: magnetic prealignment and mandrel compaction. J Biomech Eng 120, 660, 1998.
108. L'Heureux, N., Germain, L., Labbé, R., and Auger, F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 17, 499, 1993.
109. Schutte, S.C., Chen, Z., Brockbank, K.G.M., and Nerem, R.M. Cyclic strain improves strength and function of a collagen-based tissue-engineered vascular media. Tissue Eng Part A 16, 3149, 2010.
110. Seliktar, D., Black, R.A., Vito, R.P., and Nerem, R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling In vitro. Ann Biomed Eng 28, 351, 2000.
111. Buttafoco, L., Engbers-Buijtenhuijs, P., Poot, A.A., Dijkstra, P.J., Vermes, I., and Feijen, J. Physical characterization of vascular grafts cultured in a bioreactor. Biomaterials 27, 2380, 2006.
112. Deng, C., Li, F., Griffith, M., Ruel, M., and Suuronen, E.J. Application of chitosan-based biomaterials for blood vessel regeneration. Macromol Symp 297, 138, 2010.
113. Zhang, L., Ao, Q., Wang, A., Lu, G., Kong, L., Gong, Y., Zhao, N., and Zhang, X. A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. J Biomed Mater Res A 77A, 277, 2006.
114. Zhu, C., Fan, D., Duan, Z., Xue, W., Shang, L., Chen, F., and Luo, Y. Initial investigation of novel human-like collagen/chitosan scaffold for vascular tissue engineering. J Biomed Mater Res A 89A, 829, 2009.
115. Stegemann, J.P., Kaszuba, S.N., and Rowe, S.L. Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng 13, 2601, 2007.
116. Boccafoschi, F., Rajan, N., Habermehl, J., and Mantovani, D. Preparation and characterization of a scaffold for vascular tissue engineering by direct-assembling of collagen and cells in a cylindrical geometry. Macromol Biosci 7, 719, 2007.
117. Engbers-Buijtenhuijs, P., Buttafoco, L., Poot, A.A., Dijkstra, P.J., de Vos, R.A.I., Sterk, L.M.T., Geelkerken, R.H., Vermes, I., and Feijen, J. Biological characterisation of vascular grafts cultured in a bioreactor. Biomaterials 27, 2390, 2006.
118. Dubey, G., and Mequanint, K. Conjugation of fibronectin onto three-dimensional porous scaffolds for vascular tissue engineering applications. Acta Biomater 7, 1114, 2011.
119. Wang, S., Zhang, Y., Yin, G., Wang, H., and Dong, Z. Electrospun polylactide/silk fibroin-gelatin composite tubular scaffolds for small-diameter tissue engineering blood vessels. J Appl Polym Sci 113, 2675, 2009.
120. Koch, S., Flanagan, T.C., Sachweh, J.S., Tanios, F., Schnoering, H., Deichmann, T., Ellä, V., Kellomäki, M., Gronloh, N., Gries, T., Tolba, R., Schmitz-Rode, T., and Jockenhoevel, S. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 31, 4731, 2010.
121. Zhao, J., Qiu, H., Chen, D., Zhang, W., Zhang, D., and Li, M. Development of nanofibrous scaffolds for vascular tissue engineering. Int J Biol Macromol 56, 106, 2013.
122. Tillman, B.W., Yazdani, S.K., Lee, S.J., Geary, R.L., Atala, A., and Yoo, J.J. The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 30, 583, 2009.
123. Crapo, P.M., Gilbert, T.W., and Badylak, S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233, 2011.
124. Cho, S.-W., Lim, S.H., Kim, I.-K., Hong, Y.S., Kim, S.-S., Yoo, K.J., Park, H.-Y., Jang, Y., Chang, B.C., Choi, C.Y., Hwang, K.-C., and Kim, B.-S. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 241, 506, 2005.
125. Conklin, B.S., Richter, E.R., Kreutziger, K.L., Zhong, D.S., and Chen, C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 24, 173, 2002.
126. Rosenberg, N., Martinez, A., Sawyer, P.N., Wesolowski, S.A., Postlethwait, R.W., and Dillon, M.L. Tanned collagen arterial prosthesis of bovine carotid origin in man. Preliminary studies of enzyme-treated heterografts. Ann Surg 164, 247, 1966.
127. Chemla, E.S., and Morsy, M. Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. Br J Surg 96, 34, 2009.
128. Katzman, H.E., Glickman, M.H., Schild, A.F., Fujitani, R.M., and Lawson, J.H. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 201, 223, 2005.
129. Schmidli, J., Savolainen, H., Heller, G., Widmer, M.K., Then-Schlagau, U., Baumgartner, I., and Carrel, T.P. Bovine mesenteric vein graft (ProCol) in critical limb ischaemia with tissue loss and infection. Eur J Vasc Endovasc Surg 27, 251, 2004.
130. Kovalic, A.J., Beattie, D.K., and Davies, A.H. Outcome of ProCol, a bovine mesenteric vein graft, in infrainguinal reconstruction. Eur J Vasc Endovasc Surg 24, 533, 2002.
131. Schröder, A., Imig, H., Peiper, U., Neidel, J., and Petereit, A. Results of a bovine collagen vascular graft (Solcograft-P) in infrainguinal positions. Eur J Vasc Surg 2, 315, 1988.
132. Hurt, A.V., Batello-Cruz, M., Skipper, B.J., Teaf, S.R., and Sterling, W.A., Jr. Bovine carotid artery heterografts versus polytetrafluoroethylene grafts: a prospective, randomized study. Am J Surg 146, 844, 1983.
133. Sabanayagam, P., Schwartz, A.B., Soricelli, R.R., Lyons, P., and Chinitz, J. A comparative study of 402 bovine heterografts and 225 reinforced expanded PTFE grafts as AVF in the ESRD patient. Trans Am Soc Artif Intern Organs 26, 88, 1980.
134. Sawyer, P.N., Stanczewski, B., Sivakoff, S., Lucas, T., and Kirschenbaum, D. Search for the ideal collagen vascular prosthesis. Trans Am Soc Artif Intern Organs 23, 288, 1977.
135. Dukkipati, R., Peck, M., Dhamija, R., Hentschel, D.M., Reynolds, T., Tammewar, G., and McAllister, T. Biological grafts for hemodialysis access: historical lessons, state-of-the-art and future directions. Semin Dial 26, 233, 2013.
136. Li, L., Terry, C.M., Shiu, Y.-T.E., and Cheung, A.K. Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int 74, 1247, 2008.
137. Scott, E.C., and Glickman, M.H. Conduits for hemodialysis access. Semin Vasc Surg 20, 158, 2007.
138. Berardinelli, L. Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg 32, 203, 2006.
139. Madden, R.L., Lipkowitz, G.S., Browne, B.J., and Kurbanov, A. Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Ann Vasc Surg 18, 453, 2004.
140. Olausson, M., Patil, P.B., Kuna, V.K., Chougule, P., Hernandez, N., Methe, K., Kullberg-Lindh, C., Borg, H., Ejnell, H., and Sumitran-Holgersson, S. Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet 380, 230, 2012.
141. Tillman, B.W., Yazdani, S.K., Neff, L.P., Corriere, M.A., Christ, G.J., Soker, S., Atala, A., Geary, R.L., and Yoo, J.J. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg 56, 783, 2012.
142. Kaushal, S., Amiel, G.E., Guleserian, K.J., Shapira, O.M., Perry, T., Sutherland, F.W., Rabkin, E., Moran, A.M., Schoen, F.J., Atala, A., Soker, S., Bischoff, J., and Mayer, J.E. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7, 1035, 2001.
143. Piterina, A.V., Cloonan, A.J., Meaney, C.L., Davis, L.M., Callanan, A., Walsh, M.T., and McGloughlin, T.M. ECM-based materials in cardiovascular applications: inherent healing potential and augmentation of native regenerative processes. Int J Mol Sci 10, 4375, 2009.
144. Sandusky, G.E., Lantz, G.C., and Badylak, S.F. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J Surg Res 58, 415, 1995.
145. Roeder, R., Lantz, G.C., and Geddes, L.A. Mechanical remodeling of small-intestine submucosa small-diameter vascular grafts - a preliminary report. Biomed Instrum Technol 35, 110, 2000.
146. Hiles, M.C., Badylak, S.F., Lantz, G.C., Kokini, K., Geddes, L.A., and Morff, R.J. Mechanical properties of xenogeneic small-intestinal submucosa when used as an aortic graft in the dog. J Biomed Mater Res 29, 883, 1995.
147. Peng, H.-F., Liu, J.Y., Andreadis, S.T., and Swartz, D.D. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng Part A 17, 981, 2011.
148. Tosi, G.M., Massaro-Giordano, M., Caporossi, A., and Toti, P. Amniotic membrane transplantation in ocular surface disorders. J Cell Physiol 202, 849, 2005.
149. Amensag, S., and McFetridge, P.S. Rolling the human amnion to engineer laminated vascular tissues. Tissue Eng Part C Methods 18, 903, 2012.
150. Lee, P.-H., Tsai, S.-H., Kuo, L., Hwang, C.-Y., Kuo, C-Y., Yang, V.C., and Chen, J.-K. A prototype tissue engineered blood vessel using amniotic membrane as scaffold. Acta Biomater 8, 3342, 2012.
151. Peirovi, H., Rezvani, N., Hajinasrollah, M., Mohammadi, S.S., and Niknejad, H. Implantation of amniotic membrane as a vascular substitute in the external jugular vein of juvenile sheep. J Vasc Surg 56, 1098, 2012.
152. Badylak, S.F., Freytes, D.O., and Gilbert, T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 5, 1, 2009.
153. Piterina, A.V., Callanan, A., Davis, L., Meaney, C, Walsh, M., and McGloughlin, T.M. Extracellular matrices as advanced scaffolds for vascular tissue engineering. Biomed Mater Eng 19, 333, 2009.
154. Woods, A.M., Rodenberg, E.J., Hiles, M.C., and Pavalko, F.M. Improved biocompatibility of small intestinal submucosa (SIS) following conditioning by human endothelial cells. Biomaterials 25, 515, 2004.
155. Reing, J.E., Zhang, L., Myers-Irvin, J., Cordero, K.E., Freytes, D.O., Heber-Katz, E., Bedelbaeva, K., McIntosh, D., Dewilde, A., Braunhut, S.J., and Badylak, S.F. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 15, 605, 2009.
156. Grauss, R.W., Hazekamp, M.G., Oppenhuizen, F., Munsteren, C.J. van, Groot, A.C.G., and DeRuiter, M.C. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 27, 566, 2005.
157. Schenke-Layland, K., Vasilevski, O., Opitz, F., König, K., Riemann, I., Halbhuber, K.J., Wahlers, T., and Stock, U.A. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 143, 201, 2003.
158. Keane, T.J., Londono, R., Turner, N.J., and Badylak, S.F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 33, 1771, 2012.
159. Spark, J.I., Yeluri, S., Derham, C, Wong, Y.T., and Leitch, D. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br J Surg 95, 582, 2008.
160. Roy, S., Silacci, P., and Stergiopulos, N. Biomechanical proprieties of decellularized porcine common carotid arteries. Am J Physiol Heart Circ Physiol 289, H1567, 2005.
161. Simon, P., Kasimir, M.T., Seebacher, G., Weigel, G., Ullrich, R., Salzer-Muhar, U., Rieder, E., and Wolner, E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23, 1002, 2003.
162. Tosun, Z., and McFetridge, P.S. Improved recellularization of ex vivo vascular scaffolds using directed transport gradients to modulate ECM remodeling. Biotechnol Bioeng 110, 2035, 2013.
163. Gratzer, P.F., Harrison, R.D., and Woods, T. Matrix alteration and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng 12, 2975, 2006.
164. Ketchedjian, A., Jones, A.L., Krueger, P., Robinson, E., Crouch, K., Wolfinbarger, L., Jr, and Hopkins, R. Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions. Ann Thorac Surg 79, 888, 2005.
165. Butler III, H.G., Baker, L.D., Jr, and Johnson, J.M. Vascular access for chronic hemodialysis: polytetrafluoroethylene (PTFE) versus bovine heterograft. Am J Surg 134, 791, 1977.
166. Peck, M., Gebhart, D., Dusserre, N., McAllister, T.N., and L'Heureux, N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 195, 144, 2012.
167. L'Heureux, N., Stoclet, J.-C., Auger, F.A., Lagaud, G.J.L., Germain, L., and Andriantsitohaina, R. A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 15, 515, 2001.
168. McAllister, T.N., Maruszewski, M., Garrido, S.A., Wystrychowski, W., Dusserre, N., Marini, A., Zagalski, K., Fiorillo, A., Avila, H., Manglano, X., Antonelli, J., Kocher, A., Zembala, M., Cierpka, L., de la Fuente, L.M., and L'Heureux, N. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373, 1440, 2009.
169. Rosas, S.E., Joffe, M., Burns, J.E., Knauss, J., Brayman, K., and Feldman, H.I. Determinants of successful synthetic hemodialysis vascular access graft placement. J Vasc Surg 37, 1036, 2003.
170. Wystrychowski, W., McAllister, T.N., Zagalski, K., Dusserre, N., Cierpka, L., and L'Heureux, N. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J Vasc Surg 60, 1353, 2014.
171. Wystrychowski, W., Cierpka, L., Zagalski, K., Garrido, S., Dusserre, N., Radochonski, S., McAllister, T.N., and L'Heureux, N. Case study: first implantation of a frozen, devitalized tissue-engineered vascular graft for urgent hemodialysis access. J Vasc Access 12, 67, 2011.
172. L'Heureux, N., Dusserre, N., Wystrychowski, W., Garrido, S.A., MacKenzie, R., Velez, J., and McAllister, T.N. Abstracts from the emerging science series. Circulation 127, 2071, 2013.
173. Peck, M., Dusserre, N., McAllister, T.N., and L'Heureux, N. Tissue engineering by self-assembly. Mater Today 14, 218, 2011.
174. Zhao, J., Liu, L., Wei, J., Ma, D., Geng, W., Yan, X., Zhu, J., Du, H., Liu, Y., Li, L., and Chen, F. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells. Artif Organs 36, 93, 2012.
175. Bourget, J.-M., Gauvin, R., Larouche, D., Lavoie, A., Labbé, R., Auger, F.A., and Germain, L. Human fibroblast-derived ECM as a scaffold for vascular tissue engineering. Biomaterials 33, 9205, 2012.
176. Kelm, J.M., Lorber, V., Snedeker, J.G., Schmidt, D., Broggini-Tenzer, A., Weisstanner, M., Odermatt, B., Mol, A., Zünd, G., and Hoerstrup, S.P. A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol 148, 46, 2010.
177. Norotte, C., Marga, F.S., Niklason, L.E., and Forgacs, G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30, 5910, 2009.
178. Marga, F., Jakab, K., Khatiwala, C., Shepherd, B., Dorfman, S., Hubbard, B., Colbert, S., and Forgacs, G. Toward engineering functional organ modules by additive manufacturing. Biofabrication 4, 022001, 2012.
179. Poh, M., Boyer, M., Solan, A., Dahl, S.L., Pedrotty, D., Banik, S.S., McKee, J.A., Klinger, R.Y., Counter, C.M., and Niklason, L.E. Blood vessels engineered from human cells. Lancet 365, 2122, 2005.
180. McKee, J.A., Banik, S.S., Boyer, M.J., Hamad, N.M., Lawson, J.H., Niklason, L.E., and Counter, C.M. Human arteries engineered in vitro. EMBO Rep 4, 633, 2003.
181. Gao, J., Ensley, A.E., Nerem, R.M., and Wang, Y. Poly(glycerol sebacate) supports the proliferation and phenotypic protein expression of primary baboon vascular cells. J Biomed Mater Res A 83A, 1070, 2007.
182. Shapira, O.M., Xu, A., Aldea, G.S., Vita, J.A., Shemin, R.J., and Keaney, J.F. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation 100, II322, 1999.
183. Hill, J.M., Zalos, G., Halcox, J.P.J., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., and Finkel, T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348, 593, 2003.
184. Matsumura, G., Miyagawa-Tomita, S., Shin'oka, T., Ikada, Y., and Kurosawa, H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108, 1729, 2003.
185. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringdén, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31, 890, 2003.
186. Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., and Verfaillie, C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30, 896, 2002.
187. Zuk, P.A., Zhu, M., Ashjian, P., Ugarte, D.A.D., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
188. Campagnoli, C., Roberts, I.A.G., Kumar, S., Bennett, P.R., Bellantuono, I., and Fisk, N.M. Identification of mesenchymal stem/progenitor cells in human firsttrimester fetal blood, liver, and bone marrow. Blood 98, 2396, 2001.
189. Colter, D.C., Class, R., DiGirolamo, C.M., and Prockop, D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci 97, 3213, 2000.
190. Gong, Z., and Niklason, L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22, 1635, 2008.
191. Melero-Martin, J.M, Obaldia, M.E.D., Kang, S.-Y., Khan, Z.A., Yuan, L., Oettgen, P., and Bischoff, J. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103, 194, 2008.
192. Mirza, A., Hyvelin, J.-M., Rochefort, G.Y., Lermusiaux, P., Antier, D., Awede, B., Bonnet, P., Domenech, J., and Eder, V. Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. J Vasc Surg 47, 1313, 2008.
193. Hashi, C.K., Zhu, Y., Yang, G.-Y., Young, W.L., Hsiao, B.S., Wang, K., Chu, B., and Li, S. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci 104, 11915, 2007.
194. Harris, L.J., Abdollahi, H., Zhang, P., McIlhenny, S., Tulenko, T.N., and DiMuzio, P.J. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J Surg Res 168, 306, 2011.
195. Heydarkhan-Hagvall, S., Schenke-Layland, K., Yang, J.Q., Heydarkhan, S., Xu, Y., Zuk, P.A., MacLellan, W.R., and Beygui, R.E. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 187, 263, 2008.
196. Planat-Benard, V., Silvestre, J.-S., Cousin, B., André, M., Nibbelink, M., Tamarat, R., Clergue, M., Manneville, C., Saillan-Barreau, C., Duriez, M., Tedgui, A., Levy, B., Pénicaud, L., and Casteilla, L. Plasticity of human adipose lineage cells toward endothelial cells physiological and therapeutic perspectives. Circulation 109, 656, 2004.
197. Zhang, P., Moudgill, N., Hager, E., Tarola, N., DiMatteo, C., McIlhenny, S., Tulenko, T., and DiMuzio, P.J. Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev 20, 977, 2011.
198. DiMuzio, P., and Tulenko, T. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells. J Vasc Surg 45, A99, 2007.
199. Gao, Y., Liu, F., Zhang, L., Su, X., Liu, J.Y., and Li, Y. Acellular blood vessels combined human hair follicle mesenchymal stem cells for engineering of functional arterial grafts. Ann Biomed Eng 42, 2177, 2014.
200. Bajpai, V.K., Mistriotis, P., and Andreadis, S.T. Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res 8, 74, 2012.
201. Hoogduijn, M.J., Gorjup, E., and Genever, P.G. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev 15, 49, 2006.
202. Reynolds, A.J., Lawrence, C., Cserhalmi-Friedman, P.B., Christiano, A.M., and Jahoda, C.A.B. Trans-gender induction of hair follicles. Nature 402, 33, 1999.
203. Takahashi, K., and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663, 2006.
204. Hibino, N., Duncan, D.R., Nalbandian, A., Yi, T., Qyang, Y., Shinoka, T., and Breuer, C.K. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 143, 696, 2012.
205. Wang, Y., Hu, J., Jiao, J., Liu, Z., Zhou, Z., Zhao, C., Chang, L.-J., Chen, Y.E., Ma, P.X., and Yang, B. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds. Biomaterials 35, 8960, 2014.
206. Li, Z., Hu, S., Ghosh, Z., Han, Z., and Wu, J.C. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Stem Cells Dev 20, 1701, 2011.
207. Okano, H., Nakamura, M., Yoshida, K., Okada, Y., Tsuji, O., Nori, S., Ikeda, E., Yamanaka, S., and Miura, K. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112, 523, 2013.
208. Da Gama, A.D., Sarmento, C., Vieira, T., and do Carmo, G.X. The use of arterial allografts for vascular reconstruction in patients receiving immunosuppression for organ transplantation. J Vasc Surg 20, 271, 1994.
209. Kim, S.-H., Mun, C.H., Jung, Y., Kim, S.-H., Kim, D.-I., and Kim, S.H. Mechanical properties of compliant double layered poly(L-lactide-co-e-caprolactone) vascular graft. Macromol Res 21, 886, 2013.
210. Centola, M., Rainer, A., Spadaccio, C., Porcellinis, S.D., Genovese, J.A., and Trombetta, M. Combining electro-spinning and fused deposition modeling for the fabrication of a hybrid vascular graft. Biofabrication 2, 014102, 2010.
211. Song, Y., Kamphuis, M.M.J., Zhang, Z., Sterk, L.M.T., Vermes, I., Poot, A.A., Feijen, J., and Grijpma, D.W. Flexible and elastic porous poly(trimethylene carbonate) structures for use in vascular tissue engineering. Acta Biomater 6, 1269, 2010.
212. Ozolanta, I., Tetere, G., Purinya, B., and Kasyanov, V. Changes in the mechanical properties, biochemical contents and wall structure of the human coronary arteries with age and sex. Med Eng Phys 20, 523, 1998.
213. Madhavan, K., Elliott, W.H., Bonani, W., Monnet, E., and Tan, W. Mechanical and biocompatible characterizations of a readily available multilayer vascular graft. J Biomed Mater Res B Appl Biomater 101B, 506, 2013.
214. Rapoport, H.S., Fish, J., Basu, J., Campbell, J., Genheimer, C., Payne, R., and Jain, D. Construction of a tubular scaffold that mimics J-shaped stress/strain mechanics using an innovative electrospinning technique. Tissue Eng Part C Methods 18, 567, 2012.
215. Rodriguez, M., Juran, C., McClendon, M., Eyadiel, C., and McFetridge, P.S. Development of a mechanically tuneable 3D scaffold for vascular reconstruction. J Biomed Mater Res A 100A, 3480, 2012.
216. Drilling, S., Gaumer, J., and Lannutti, J. Fabrication of burst pressure competent vascular grafts via electrospin-ning: effects of microstructure. J Biomed Mater Res A 88A, 923, 2009.
217. Stekelenburg, M., Rutten, M.C.M., Snoeckx, L.H.E.H, and Baaijens, F.P.T. Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts. Tissue Eng Part A 15, 1081, 2009.
218. Tschoeke, B., Flanagan, T.C., Koch, S., Harwoko, M.S., Deichmann, T., Ellå, V., Sachweh, J.S., Kellomåki, M., Gries, T., Schmitz-Rode, T., and Jockenhoevel, S. Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A 15, 1909, 2009.
219. Roh, J.D., Nelson, G.N., Brennan, M.P., Mirensky, T.L., Yi, T., Hazlett, T.F., Tellides, G., Sinusas, A.J., Pober, J.S., Saltzman, W.M., Kyriakides, T.R., and Breuer, C.K. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 29, 1454, 2008.
220. Stitzel, J., Liu, J., Lee, S.J., Komura, M., Berry, J., Soker, S., Lim, G., Van Dyke, M., Czerw, R., Yoo, J.J., and Atala, A. Controlled fabrication of a biological vascular substitute. Biomaterials 27, 1088, 2006.
221. Torikai, K., Ichikawa, H., Hirakawa, K., Matsumiya, G., Kuratani, T., Iwai, S., Saito, A., Kawaguchi, N., Matsuura, N., and Sawa, Y. A self-renewing, tissue-engineered vascular graft for arterial reconstruction. J Thorac Cardiovasc Surg 136, 37, 2008.
222. Patel, A., Fine, B., Sandig, M., and Mequanint, K. Elastin biosynthesis: the missing link in tissue-engineered blood vessels. Cardiovasc Res 71, 40, 2006.
223. Cribb, A.M., and Scott, J.E. Tendon response to tensile stress: an ultrastructural investigation of collagen: proteoglycan interactions in stressed tendon. J Anat 187, 423, 1995.
224. Diamant, J., Keller, A., Baer, E., Litt, M., and Arridge, R.G.C. Collagen; ultrastructure and its relation to mechanical properties as a function of ageing. Proc R Soc Lond B Biol Sci 180, 293, 1972.
225. Stankus, J.J., Soletti, L., Fujimoto, K., Hong, Y., Vorp, D.A., and Wagner, W.R. Fabrication of cell micro-integrated blood vessel constructs through electro-hydrodynamic atomization. Biomaterials 28, 2738, 2007.
226. Higgins, S.P., Solan, A.K., and Niklason, L.E. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A 67A, 295, 2003.
227. Ramamurthi, A., and Vesely, I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 26, 999, 2005.
228. Long, J.L., and Tranquillo, R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22, 339, 2003.
229. Davidson, J.M., LuValle, P.A., Zoia, O., Quaglino, D., and Giro, M. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J Biol Chem 272, 345, 1997.
230. Hayashi, A., Suzuki, T., and Tajima, S. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J Biochem (Tokyo) 117, 132, 1995.
231. Seliktar, D., Nerem, R.M., and Galis, Z.S. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng 9, 657, 2003.
232. Kim, B.-S., Nikolovski, J., Bonadio, J., Smiley, E., and Mooney, D.J. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res 251, 318, 1999.
233. Kim, B.-S., Nikolovski, J., Bonadio, J., and Mooney, D.J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol. 17, 979, 1999.
234. Huang, A.H., Lee, Y., Humphrey, J.D., and Niklason, L.E. Biaxial stretch results in formation of mature functional elastic fibers in engineered vessels. Angiogenesis 17, 275, 2014.
235. Davis, E.C. Elastic lamina growth in the developing mouse aorta. J Histochem Cytochem 43, 1115, 1995.
236. Bendeck, M.P., and Langille, B.L. Rapid accumulation of elastin and collagen in the aortas of sheep in the immediate perinatal period. Circ Res 69, 1165, 1991.
237. Gerrity, R.G., and Cliff, W.J. The aortic tunica media of the developing rat. I. Quantitative stereologic and biochemical analysis. Lab Investig J Tech Methods Pathol 32, 585, 1975.
238. Looker, T., and Berry, C.L. The growth and development of the rat aorta. II. Changes in nucleic acid and scleroprotein content. J Anat 113, 17, 1972.
239. ∗. Annu Rev Fluid Mech 40, 367, 2008.
240. Hughes, P.E., and How, T.V. Effects of geometry and flow division on flow structures in models of the distal end-to-side anastomosis. J Biomech 29, 855, 1996.
241. Bassiouny, H.S., White, S., Glagov, S., Choi, E., Giddens, D.P., and Zarins, C.K. Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg 15, 708, 1992.
242. Hofer, M., Rappitsch, G., Perktold, K., Trubel, W., and Schima, H. Numerical study of wall mechanics and fluid dynamics in end-to-side anastomoses and correlation to intimal hyperplasia. J Biomech 29, 1297, 1996.
243. Steinman, D.A., and Ethier, C.R. The effect of wall distensibility on flow in a two-dimensional end-to-side anastomosis. J Biomech Eng 116, 294, 1994.
244. O'Brien, T., Walsh, M., and McGloughlin, T. On reducing abnormal hemodynamics in the femoral end-to-side anastomosis: the influence of mechanical factors. Ann Biomed Eng 33, 310, 2005.
245. Longest, P.W., Kleinstreuer, C., and Archie, J.P., Jr. Particle hemodynamics analysis of Miller cuff arterial anastomosis. J Vasc Surg 38, 1353, 2003.
246. Cole, J.S., Watterson, J.K., and O'Reilly, M.J.G. Numerical investigation of the haemodynamics at a patched arterial bypass anastomosis. Med Eng Phys 24, 393, 2002.
247. Khalil, A.A., Boyd, A., and Griffiths, G. Interposition vein cuff for infragenicular prosthetic bypass graft. Cochrane Database Syst Rev [Internet]. John Wiley & Sons, Ltd; 2012 [cited 2014 May 3]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007921.pub2/abstract
248. Gough, M.J. Comments regarding "PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study." Eur J Vasc Endovasc Surg 39, 755, 2010.
249. Griffiths, G.D., Nagy, J., Black, D., and Stonebridge, P.A. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg 91, 560, 2004.
250. Yeung, K.K., Mills, J.L., Sr, Hughes, J.D., Berman, S.S., Gentile, A.T., and Westerband, A. Improved patency of infrainguinal polytetrafluoroethylene bypass grafts using a distal Taylor vein patch. Am J Surg 182, 578, 2001.
251. Donker, J.M.W., Ho, G.H., Slaa, A. te, Groot, H.G.W. de, Waal, J.C.H. van der, Veen, E.J., and Laan, L. van der. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease. Vasc Endovascular Surg 45, 598, 2011.
252. Panneton, J.M., Hollier, L.H., and Hofer, J.M. Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetra-fluoroethylene graft for infragenicular arterial bypass. Ann Vasc Surg 18, 199, 2004.
253. Sorom, A.J., Hughes, C.B., McCarthy, J.T., Jenson, B.M., Prieto, M., Panneton, J.M., Sterioff, S., Stegall, M.D., and Nyberg, S.L. Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemo-dialysis vascular access. Surgery 132, 135, 2002.
254. Chua, L.P., Tong, J.H., and Zhou, T. Numerical simulation of steady flows in designed sleeve models at distal anastomoses. Int Commun Heat Mass Transfer 32, 707, 2005.
255. O'Brien, T.P., Grace, P., Walsh, M., Burke, P., and McGloughlin, T. Computational investigations of a new prosthetic femoral-popliteal bypass graft design. J Vasc Surg 42, 1169, 2005.
256. Longest, P.W., and Kleinstreuer, C. Computational haemodynamics analysis and comparison study of arteriovenous grafts. J Med Eng Technol 24, 102, 2000.
257. Lei, M., Archie, J.P., and Kleinstreuer, C. Computational design of a bypass graft that minimizes wall shear stress gradients in the region of the distal anastomosis. J Vasc Surg 25, 637, 1997.
258. Qiao, A., and Liu, Y. Influence of graft-host diameter ratio on the hemodynamics of CABG. Biomed Mater Eng 16, 189, 2006.
259. Papaharilaou, Y., Doorly, D.J., and Sherwin, S.J. The influence of out-of-plane geometry on pulsatile flow within a distal end-to-side anastomosis. J Biomech 35, 1225, 2002.
260. Jackson, Z.S., Ishibashi, H., Gotlieb, A.I., and Langille, B.L. Effects of anastomotic angle on vascular tissue responses at end-to-side arterial grafts. J Vasc Surg 34, 300, 2001.
261. Ojha, M., Cobbold, R.S.C., and Johnston, K.W. Influence of angle on wall shear stress distribution for an end-to-side anastomosis. J Vasc Surg 19, 1067, 1994.
262. Rickard, R.F., Meyer, C., and Hudson, D.A. Computational modeling of microarterial anastomoses with size discrepancy (small-to-large). J Surg Res 153, 1, 2009.
263. Migliavacca, F., and Dubini, G. Computational modeling of vascular anastomoses. Biomech Model Mechanobiol 3, 235, 2005.
264. Mendelson, K., Aikawa, E., Mettler, B.A., Sales, V., Martin, D., Mayer, J.E., and Schoen, F.J. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep. Cardiovasc Pathol 16, 277, 2007.
265. Burn, T.C., Petrovick, M.S., Hohaus, S., Rollins, B.J., and Tenen, D.G. Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood 84, 2776, 1994.
266. Weber, B., Emmert, M.Y., Schoenauer, R., Brokopp, C., Baumgartner, L., and Hoerstrup, S.P. Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol 33, 307, 2011.
267. Hibino, N., Yi, T., Duncan, D.R., Rathore, A., Dean, E., Naito, Y., Dardik, A., Kyriakides, T., Madri, J., Pober, J.S., Shinoka, T., and Breuer, C.K. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 25, 4253, 2011.
268. Brown, B.N., Ratner, B.D., Goodman, S.B., Amar, S., and Badylak, S.F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 33, 3792, 2012.
269. Rehman, J., Li, J., Orschell, C.M., and March, K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164, 2003.
270. Roh, J.D., Sawh-Martinez, R., Brennan, M.P., Jay, S.M., Devine, L., Rao, D.A., Yi, T., Mirensky, T.L., Nalbandian, A., Udelsman, B., Hibino, N., Shinoka, T., Saltzman, W.M., Snyder, E., Kyriakides, T.R., Pober, J.S., and Breuer, C.K. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci 107, 4669, 2010.
271. Swartz, D.D., and Andreadis, S.T. Animal models for vascular tissue-engineering. Curr Opin Biotechnol 24, 916, 2013.
272. Byrom, M.J., Bannon, P.G., White, G.H., and Ng, M.K.C. Animal models for the assessment of novel vascular conduits. J Vasc Surg 52, 176, 2010.
273. Rashid, S.T., Salacinski, H.J., Hamilton, G., and Seifalian, A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 25, 1627, 2004.
274. Peng, H., Schlaich, E.M., Row, S., Andreadis, S.T., and Swartz, D.D. A novel ovine ex vivo arteriovenous shunt model to test vascular implantability. Cells Tissues Organs 195, 108, 2012.
275. Dahl, S.L.M., Blum, J.L., and Niklason, L.E. Bioengineered vascular grafts: can we make them off-the-shelf? Trends Cardiovasc Med 21, 83, 2011.
276. Plagnol, A.C., Rowley, E., Martin, P., and Livesey, F. Industry perceptions of barriers to commercialization of regenerative medicine products in the UK. Regen Med 4, 549, 2009.
277. Bertram, T.A., Tentoff, E., Johnson, P.C., Tawil, B., Van Dyke, M., and Hellman, K.B. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Tissue Eng Part A 18, 2187, 2012.
278. Jaklenec, A., Stamp, A., Deweerd, E., Sherwin, A., and Langer, R. Progress in the tissue engineering and stem cell industry "are we there yet?" Tissue Eng Part B Rev 18, 155, 2012.
279. Tillman, B., Hardin-Young, J., Shannon, W., Russell, A.J., and Parenteau, N.L. Meeting the need for regenerative therapies: translation-focused analysis of U.S. regenerative medicine opportunities in cardiovascular and peripheral vascular medicine using detailed incidence data. Tissue Eng Part B Rev 19, 99, 2013.
280. Parenteau, N.L. Driving the bumpy road to commercialization. Tissue Eng Part A 20, 1563, 2014.